Your browser doesn't support javascript.
loading
Glycoform Modification of Secreted Recombinant Glycoproteins through Kifunensine Addition during Transient Vacuum Agroinfiltration.
Xiong, Yongao; Li, Qiongyu; Kailemia, Muchena J; Lebrilla, Carlito B; Nandi, Somen; McDonald, Karen A.
Affiliation
  • Xiong Y; Department of Chemical Engineering and Materials Science, University of California, Davis, CA 95616, USA. yxiong@ucdavis.edu.
  • Li Q; Department of Chemistry, University of California, Davis, CA 95616, USA. qyuli@ucdavis.edu.
  • Kailemia MJ; Department of Chemistry, University of California, Davis, CA 95616, USA. jkmuchena@ucdavis.edu.
  • Lebrilla CB; Department of Chemistry, University of California, Davis, CA 95616, USA. cblebrilla@ucdavis.edu.
  • Nandi S; Department of Biochemistry and Molecular Medicine, University of California, Davis, CA 95616, USA. cblebrilla@ucdavis.edu.
  • McDonald KA; Department of Chemical Engineering and Materials Science, University of California, Davis, CA 95616, USA. snandi@ucdavis.edu.
Int J Mol Sci ; 19(3)2018 Mar 17.
Article in En | MEDLINE | ID: mdl-29562594
ABSTRACT
Kifunensine, a potent and selective inhibitor of class I α-mannosidases, prevents α-mannosidases I from trimming mannose residues on glycoproteins, thus resulting in oligomannose-type glycans. We report for the first time that through one-time vacuum infiltration of kifunensine in plant tissue, N-linked glycosylation of a recombinant protein transiently produced in whole-plants shifted completely from complex-type to oligomannose-type. Fc-fused capillary morphogenesis protein 2 (CMG2-Fc) containing one N-glycosylation site on the Fc domain, produced in Nicotiana benthamiana whole plants, served as a model protein. The CMG2-Fc fusion protein was produced transiently through vacuum agroinfiltration, with and without kifunensine at a concentration of 5.4 µM in the agroinfiltration suspension. The CMG2-Fc N-glycan profile was determined using LC-MS/MS with a targeted dynamic multiple reaction monitoring (MRM) method. The CMG2-Fc expression level in the infiltrated plant tissue and the percentage of oligomannose-type N-glycans for kifunensine treated plants was 874 mg/kg leaf fresh weight (FW) and 98.2%, respectively, compared to 717 mg/kg leaf FW and 2.3% for untreated plants. Oligomannose glycans are amenable to in vitro enzymatic modification to produce more human-like N-glycan structures that are preferred for the production of HIV-1 viral vaccine and certain monoclonal antibodies. This method allows glycan modifications using a bioprocessing approach without compromising protein yield or modification of the primary sequence, and could be expanded to other small molecule inhibitors of glycan-processing enzymes. For recombinant protein targeted for secretion, kifunensine treatment allows collection of glycoform-modified target protein from apoplast wash fluid (AWF) with minimal plant-specific complex N-glycan at higher starting purity and concentration than in whole-leaf extract, thus simplifying the downstream processing.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Glycoproteins / Alkaloids / Enzyme Inhibitors Limits: Humans Language: En Journal: Int J Mol Sci Year: 2018 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Glycoproteins / Alkaloids / Enzyme Inhibitors Limits: Humans Language: En Journal: Int J Mol Sci Year: 2018 Document type: Article Affiliation country: United States